Royal Bank of Canada Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $64.00

Acadia Healthcare (NASDAQ:ACHC) had its target price lowered by investment analysts at Royal Bank of Canada from $94.00 to $64.00 in a research note issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 74.01% from the company’s current price.

Several other equities analysts have also commented on ACHC. Deutsche Bank Aktiengesellschaft upped their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Barclays dropped their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Finally, StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $83.33.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock traded down $1.04 during trading on Monday, reaching $36.78. The company’s stock had a trading volume of 328,858 shares, compared to its average volume of 1,000,363. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The company has a market capitalization of $3.42 billion, a P/E ratio of 12.06, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33. The business has a 50 day moving average price of $58.05 and a 200-day moving average price of $65.55.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently modified their holdings of ACHC. Point72 Asset Management L.P. boosted its stake in shares of Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after acquiring an additional 1,650,040 shares in the last quarter. Wellington Management Group LLP raised its holdings in Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares in the last quarter. Millennium Management LLC raised its holdings in Acadia Healthcare by 3,067.8% during the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares in the last quarter. Holocene Advisors LP raised its holdings in Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock valued at $61,667,000 after buying an additional 649,997 shares in the last quarter. Finally, William Blair Investment Management LLC raised its holdings in Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after buying an additional 604,070 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.